King D S
J Med Ethics. 1999 Apr;25(2):176-82. doi: 10.1136/jme.25.2.176.
Preimplantation genetic diagnosis (PID) is often seen as an improvement upon prenatal testing. I argue that PID may exacerbate the eugenic features of prenatal testing and make possible an expanded form of free-market eugenics. The current practice of prenatal testing is eugenic in that its aim is to reduce the numbers of people with genetic disorders. Due to social pressures and eugenic attitudes held by clinical geneticists in most countries, it results in eugenic outcomes even though no state coercion is involved. I argue that technological advances may soon make PID widely accessible. Because abortion is not involved, and multiple embryos are available, PID is radically more effective as a tool of genetic selection. It will also make possible selection on the basis of non-pathological characteristics, leading, potentially, to a full-blown free-market eugenics. For these reasons, I argue that PID should be strictly regulated.
植入前基因诊断(PID)通常被视为产前检测的一种改进。我认为,PID可能会加剧产前检测的优生特征,并使一种扩展形式的自由市场优生学成为可能。当前的产前检测实践具有优生性质,因为其目的是减少患有遗传疾病的人数。由于大多数国家临床遗传学家所面临的社会压力和优生态度,即使没有国家强制力介入,它也会导致优生结果。我认为技术进步可能很快会使PID广泛可用。由于不涉及堕胎,并且有多个胚胎可供选择,PID作为一种基因选择工具从根本上来说更有效。它还将使基于非病理特征的选择成为可能,这可能会导致全面的自由市场优生学。出于这些原因,我认为应该对PID进行严格监管。